Skip to main content
Loading
The recognized voice of expertise in college health
Login
Donate
Join ACHA
Keyword Search
ACHA Connect
Contact Us
Career Center
Marketplace
Buyers Guide
Cart
Toggle search
Toggle navigation
Keyword Search
Sign In
About
Toggle
About ACHA
ACHA News
History
Toggle
Land Acknowledgement
Brief History
Past Presidents
ACHA's 100th Anniversary
Board of Directors
Governance
Toggle
Elections
Bylaws and Assembly of Representatives
Board Policies and Procedures
Awards and Fellows
Toggle
Nominations
Recipients
Staff
Organizational Positions
Strategic Plan
Organizational Structure
Promotional Opportunities
Careers at ACHA
Membership
Toggle
About Our Members
Becoming a Member
Learn About Our New Member Model
Directory
Find My School
Member Seals
Roster Manager
Volunteer Leadership
Toggle
Volunteer Leader Learning Center
Leadership Recruitment and Development
Orientation Schedule
Events & Education
Toggle
Annual Meeting
Toggle
2022 Annual Meeting
2021 Annual Meeting
Future Annual Meeting Dates
Education Center
Leadership & Innovations Summits
Toggle
2019 Summit
2018 Summit
2017 Summit
COVID-19 Virtual Summit
Toggle
About the Summit
Agenda
Sponsor the Summit
Meet Our Sponsors
COVID-19 Virtual Summit 2
Health Equity Summit
Resources
Toggle
CoVAC: Campus COVID-19 Vaccination and Mitigation
COVID-19
Toggle
COVID-19 Resources
Mass Vaccination Guidance and Resources
Career Center
Toggle
Careers in College Health and Wellness
Careers at ACHA
College Health Topics (A-Z)
Guidelines, Recommendations, and White Papers
Publications
Toggle
Print Brochures
E-Brochures
Framework for College Health
Salary Survey
Action Newsletter
Healthy Campus Executive Update
Journal
Addressing Sexual and Relationship Violence Toolkit
The Healthy Campus Framework
Survey Data
Toggle
National College Health Assessment
Sexual Health Services Survey
Benchmarking
ACHA YouTube Channel
Vision Into Action
Networks
Toggle
By Region (affiliates)
By Interest (committees/coalitions)
By Discipline (sections)
Networking Events
Discussion Groups
Liasion Relationships
Programs & Services
Toggle
College Health and Wellness Consulting
Toggle
COVID-19 Consulting
Connected College Health Network
Toggle
How to Participate
CoVAC: Campus COVID-19 Vaccination and Mitigation
Healthy Campus
Leadership Institute
Toggle
CHWP Certification Program
National College Health Assessment
National Faculty and Staff Health Assessment
Patient Satisfaction Assessment Service
Virtual Mentoring
Foundation
Toggle
About ACHF
ACHF Funds
How to Contribute
Apply for Funding
Foundation Dollars at Work
Recognizing Donors
ACHF Events
ACHF Newsletter
Partner Resources
Toggle
Aetna Well-Being Projects
Healthy Students: Our Gift to the Future
Skip breadcrumb navigation
Tuberculosis Screening and Testing of College and University Students
Works Cited for
Frequently Asked Questions
Alexander, B. "Good Policies on Student Vaccination Can Inoculate Colleges Against Risk" The Chronicle of Higher Education, March 5, 2004.
Centers for Disease Control and Prevention. Testing & Diagnosis. Testing for TB Infection. May 2011.
http://www.cdc.gov/tb/topic/testing/default.htm
. Accessed December 2011.
Hennessey KA, Schulte JM, Cook L, Collins M, Onorato I, Valway SE. Tuberculin skin test screening practices among U.S. colleges and universities. JAMA 1998; 280(23):2008:12.
United States. Department of Homeland Security. Yearbook of Immigration Statistics: 2010. Washington, D.C.: U.S. Department of Homeland Security, Office of Immigration Statistics, 2011.
Braden CR. Infectiousness of a university student with laryngeal and cavitary tuberculosis. Clin Infect Dis 1995:21:565-70.
Colorado Department of Public Health and Environment. 2007 Guidelines for Tuberculosis Screening of College and University Students.
http://www.cdphe.state.co.us/dc/tb/CollegeTBscreen.pdf
. Accessed December 2011.
Miller, McNabb, Hisenrath, Pasipanodya, Drewyer, and Weiss. The Societal Cost of Tuberculosis: Tarrant County, Texas, 2002. AEP; 2010; 20 (1): 1-7.
Fleming R, Wolf J. Responding to MDR-TB Outbreak on Campus. ACHA Annual Meeting. Phoenix, AZ. June 1, 2011.
Centers for Disease Control and Prevention. Recommendations for Prevention and Control of TB Among Foreign-Persons: Report of the Working Group on TB Among Foreign-Persons. MMWR 1998;47(No. RR-16).
Centers for Disease Control and Prevention. Core curriculum on Tuberculosis: What the clinician should know. 5th ed. Atlanta, GA: US Department of Health and Human Services, CDC, 2011.
http://www.cdc.gov/tb/education/corecurr/pdf/chapter1.pdf
.
World Health Organization. Stop TB Partnership. Tuberculosis Country Profiles. 2011.
http://www.stoptb.org/countries/tbdata.asp
. Accessed December 20.2011.
Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection. MMWR 2010;59(No. RR-5):1-28.
Centers for Disease Control and Prevention. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings. MMWR 2005; 54 (No. RR-17):12.
Horsburgh C. & Rubin E. (2011). Latent tuberculosis infection in the United States. The New England Journal of Medicine, 3674(15), 1441-1448.
Sahni et al. Does the Implementation of an Interferon-γ Release Assay in Lieu of a Tuberculin Skin Test Increase Acceptance of Preventive Therapy for Latent Tuberculosis Among Healthcare Workers? Infection Control and Hospital Epidemiology , Vol. 30, No. 2 (February 2009), pp. 197-199.
Pai M, Zwerling A, Menzies D. T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection Annals of Internal Medicine 2008;149:177-184.
Centers for Disease Control and Prevention. Core curriculum on Tuberculosis: What the clinician should know. 5th ed. Atlanta, GA: US Department of Health and Human Services, CDC, 2011. p. 82.
Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:1.
Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest. 2010;137:952-968.
Ritz N, Yau C, Connell TG, Tebruegge M, Leslie D, Curtis N. Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis. 2011;15:767-769.
Sauzullo I, Massetti AP, Mengoni F, Rossi R, et al. Influence of previous tuberculin skin test on serial IFN-gamma release assays. Tuberculosis. 2011;91:322-326.
Van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review. PLoS ONE. 2009;4:e8517.
Heymann, D. Control of Communicable Diseases Manual, 19th edition. American Public Health Association, 2008, pp. 645 – 646.
Centers for Disease Control and Prevention. Questions and Answers About TB. June 2011.
http://www.cdc.gov/tb/publications/faqs/qa_introduction.htm#Intro3
Accessed August 4, 2011.
Centers for Disease Control and Prevention. Questions and Answers About TB. Glossary. July 2010.
http://www.cdc.gov/tb/publications/faqs/qa_glossary.htm
. Accessed August 4, 2011.
Centers for Disease Control and Prevention. Questions and Answers About TB. Latent TB Infection. July 2010.
http://www.cdc.gov/tb/publications/faqs/qa_latenttbinf.htm#Latent1
Accessed August 4, 2011.
Centers for Disease Control and Prevention. Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis. MMWR December 16, 2005 / 54(RR15);1-37.
Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers, Appendix C.
http://www.cdc.gov/tb/publications/LTBI/appendixC.htm
. Accessed August 5, 2011.
Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers.
http://www.cdc.gov/tb/publications/LTBI/diagnosis.htm
. Accessed August 5, 2011.
Centers for Disease Control and Prevention. Interferon-Gamma Release Assays (IGRAs) — Blood Tests for TB Infection.
http://www.cdc.gov/tb/publications/factsheets/testing/IGRA.htm
. Accessed December 20, 2011.
Centers for Disease Control and Prevention. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR 2005;54(No.RR-17):12, 81-83.
American Thoracic Society, CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6).
Resources
College Health Topics (A-Z)
Guidelines, Recommendations, and White Papers
Publications
ACHA YouTube Channel
Survey Data
Vision Into Action
Career Center
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##